Telehealth: From Research to Mainstream Practice
Submitting Institution
University of HullUnit of Assessment
Allied Health Professions, Dentistry, Nursing and PharmacySummary Impact Type
SocietalResearch Subject Area(s)
Medical and Health Sciences: Cardiorespiratory Medicine and Haematology, Nursing, Public Health and Health Services
Summary of the impact
Academics from the University of Hull led a programme of research that
demonstrated for the first time that telehealth (the use of technology to
support remotely the delivery of healthcare) could improve clinical
outcomes for patients with heart failure.
The University's Centre for Telehealth is now recognised internationally
as a leader in this area, has been identified as an exemplar of best
practice, and is highly influential in developing national and European
guidelines. The Centre's activities have supported the development of
telehealth services for thousands of patients within the UK and Europe. It
is also a key player in initiatives devoted to the enhancement of
telehealth services through supporting industry and training of the health
and social care workforces.
Underpinning research
A systematic review of telehealth/telemonitoring in heart failure carried
out by researchers from the University of Hull (see Ref 1) was preparatory
work for a 426-participant randomised controlled trial led by Professor
John Cleland (The Trans-European Network-Home-care Management System
(TEN-HMS) — Ref 2). This was a seminal study in the development of
telehealth services for heart failure patients as it showed that patients
supported by home-based, remote monitoring of vital signs and symptoms
(telemonitoring) had significantly lower one-year mortality rates than
those receiving usual heart failure care (Usual Care one-year mortality of
45% vs Home Telemonitoring one-year mortality of 29%). This study
was the first to demonstrate clearly the potential of telemonitoring for
improving clinical outcomes in patients diagnosed with heart failure.
In addition to providing evidence to support the general approach of
home-based telemonitoring in heart failure patients, subsequent data
analysis from TEN-HMS yielded additional insight into how best to apply
the new technology in practice. Jufen Zhang and colleagues from the
University of Hull (Dr Kevin Goode and Professor Cleland) carried out
retrospective analysis of TEN-HMS data to develop greater understanding of
the effectiveness of weight monitoring algorithms in predicting the
likelihood of heart failure hospitalisation (Ref 3). The study identified
that a particular computer-based algorithm (moving average convergence
divergence) is more specific but less sensitive than simple `rule of
thumb' approaches to weight monitoring in predicting heart failure
hospitalisation. The study also identified the weaknesses of monitoring
weight alone, highlighting the need for other indicators (e.g. pulse rate
and symptoms) to be tracked in parallel.
Data from TEN-HMS continue to feed into the development of the evidence
base and understanding of heart failure. Recent work based upon TEN-HMS
data has provided insight into the stratification and identification of
risk in heart failure patients, highlighting the importance of indicators
such as NT-proBNP levels and recent history of myocardial infarction (Ref
4).
Academics from the University of Hull have also contributed to systematic
reviews of telehealth in which findings from TEN-HMS have been included.
For example, a Cochrane review of telemonitoring in heart failure — led by
a University of Hull team — found that telemonitoring was associated with
a 34% reduction in all-cause mortality and 21% reduction in heart failure
related admissions when compared to usual care (Ref 5). A subsequent
review of patients following discharge from hospital following admission
with heart failure demonstrated beneficial trends in outcomes, including a
23% reduction in all-cause mortality, associated with telemonitoring (Ref
6).
The research in Hull was undertaken between 2003 and 2013, primarily by
Professor John Cleland (Professor in Cardiology since 1999), Dr Kevin
Goode (research fellow since 2001) and Jufen Zhang (Statistical analyst).
References to the research
1) Louis AA, Turner T, Gretton M, Baksh A, Cleland JG. A systematic
review of telemonitoring for the management of heart failure. Eur J
Heart Fail. 2003 Oct;5(5):583-90.
2) Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS
Investigators. Noninvasive home telemonitoring for patients with heart
failure at high risk of recurrent admission and death: the Trans-European
Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol.
2005 May 17;45(10):1654-64.
3) Zhang J, Goode KM, Cuddihy PE, Cleland JGF. Predicting hospitalisation
due to worsening heart failure using daily weight measurement: an analysis
of the Trans-European Network-Home-Care Management System (TEN-HMS) Study.
Eur J Heart Fail 2009; Apr;11(4):420-427.
4) Zhang J, Goode KM, Rigby A, Balk AHMM, Cleland JGF. Identifying
patients at risk of death or hospitalisation due to worsening heart
failure using decision tree analysis: Evidence from the Trans-European
Network-Home-Care Management System (TEN-HMS) Study Int J Cardiol
2013 Feb 20; 163(2):149-156
5) Inglis SC, Clark RA, McAlister F, Ball J, Lewinter C, Cullington
D,Stewart S, Cleland JG. Structured telephone support or telemonitoring
programs for patients with chronic heart failure (Protocol). Cochrane
Database of Systematic Reviews; 2010 Aug 4; (8): CD007228. Review.
6) Remote monitoring after recent hospital discharge in patients with
heart failure: a systematic review and network meta-analysis. Pandor A,
Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, Cleland JG,
Cowie MR, Wong R. Heart. 2013 May 16. [Epub ahead of print]
Details of the impact
The findings of TEN-HMS and the subsequent systematic reviews have had a
substantial impact on the development of telemonitoring and — more broadly
— telehealth services locally, nationally and internationally1.
Much of the impact since 2009 has been facilitated through the University
of Hull's `Centre for Telehealth', a cross-faculty collaboration
established to further the development and delivery of remote care
services.
The initial impact of TEN-HMS was the development of a telehealth service
for heart failure patients in Hull. Not only was the development of this
service a direct result of the benefits seen in the TEN-HMS study, but the
clinical triage of remotely collected patient data was (and still is)
carried out by clinical staff appointed jointly by the University of Hull
and the NHS. Since July 2009, the heart failure telemonitoring service has
been commissioned directly by NHS Hull, accounting for approximately
£1million of healthcare spending. Between 2009 and 2011, telehealth
services in Hull were co-ordinated through a multi-agency stakeholder
group, led by Hull City Council and including Professor Cleland and other
representatives from the University of Hull. This innovative and inclusive
commissioning and governance arrangement has received national attention,
notably being cited as best practice in a King's Fund publication on
enhancing the adoption of telehealth2.
Over 400 heart failure patients in Hull have benefited from telehealth
services. Evaluations carried out on behalf of commissioners have
suggested that for every 10 patients receiving the service, one all-cause
hospital admission is averted every month. This reduction in admissions
has yielded commissioners net savings of at least £100k/year3.
The success of the Hull heart failure service provided the catalyst for
long-term, larger-scale commissioning of telehealth services in the city.
Hull's Clinical Commissioning Group now invests over £250k per annum into
telehealth services, with a recruitment target of 1000 patients by 2015.
As key players in the development, delivery and evaluation of telehealth
in Hull, the University is represented on both the commissioning and
delivery groups associated with this service.
The expertise and methodologies developed in local services have spread
nationally. Evaluations of telehealth services — which are used to inform
future service development and commissioning — have been carried out (or
are being carried out) by the University's Faculty of Health and Social
Care (FHSC) on behalf of NHS East Riding of Yorkshire, NHS Stoke-on-Trent,
NHS South of Tyne and Wear, NHS Durham and Merck Sharp & Dohme (MSD).
Overall, these projects encompass over 1000 patients and healthcare
investment of over £1M. Where these evaluations have been completed, they
have informed the targeting of resources to provide greater efficiency in
care delivery — for example, data from the NHS Stoke-on-Trent evaluation
underpinned a shift in investment toward simpler, text-based
telemonitoring services3.
In 2011-12, the University's reputation for understanding and
implementing telehealth led to participation in a £900k Yorkshire and the
Humber Strategic Health Authority (SHA) funded project to develop a
regional `Telehealth Hub'. The University contribution — led by FHSC —
involved support and evaluation of telephone coaching, video-consultation
and telemonitoring services across Hull, Barnsley and Airedale. A full
evaluation report was published by 2020Health, concluding that the hub
benefitted 2100 patients and yielded over £500k in savings4.
The Telehealth Hub has been recognised as a Reference site for the
European Innovation Partnership on Active and Healthy Ageing. The hub is
one of 32 reference sites across the EU, and one of only 13 who received a
three-star rating — the highest awarded during the evaluation process5.
Further international recognition has been gained by staff from the
University of Hull being invited to participate in a best practice
telehealth exchange programme between the UK Department of Health and the
Veterans' Health Administration in the USA6.
The University's telehealth research also continues to have a major
impact on policy and international guidelines for heart failure
management. Studies stemming directly from TEN-HMS (Ref 2 and 3) are
heavily cited within European Society of Cardiology guidelines on the
self-care management of heart failure7, and were included in a
recent NIHR Health Technology Assessment that highlighted the clinical
benefits of telemonitoring in heart failure patients8.
The impact of Hull's telehealth research has also enhanced the delivery
of care through work with industry partners, educational organisations and
skills sector bodies. Philips Healthcare was an industry partner in the
TEN-HMS study, through the use of their Motiva telehealth system. The
study gave Philips a platform for developing and marketing Motiva, thereby
building sales and enhancing services. Motiva is now one of the
market-leading telehealth systems and was used within the Department of
Health's flagship telehealth RCT, the Whole System Demonstrator. Philips
have a Master Research Agreement with the University of Hull. This
agreement not only enhances current telehealth products and services, but
also maintains a strong collaboration between industry and academia
facilitating effective and on-going knowledge transfer9.
FHSC has an on-going relationship with Virtual College; a private
provider of online education. Staff from FHSC contributed to the
development of an eLearning module focusing on Telehealth, which was made
available nationally. This module has now been accessed by over 1000
students nationwide. FHSC has continued to work with Virtual College on
developing a new Assistive Technology learning and development framework
(and associated learning resources) on behalf of Skills for Care10.
In addition, the University is working closely with Skills for Health to
review and refresh National Occupational Standards for Assistive
Technologies — new standards will be published early in 2014.
Sources to corroborate the impact
- HEFCE cited the impact of the University of Hull in developing
telehealth services in its 2011 review of HEIF case studies —
www.hefce.ac.uk/media/hefce1/news/hefce/2011/HEIFcasestudies_2011.pdf
- The multi-agency approach to telehealth delivery is cited as good
practice in; Clark M, Goodwin N (2010) Sustaining innovation in
telehealth and telecare. King's Fund, London (p24).
- Evaluations of local services, such as those in Hull and the East
Riding of Yorkshire, can be found at; http://www2.hull.ac.uk/administration/business/centrefortelehealth/evaluations.aspx.
These reports were commissioned and approved by local services, but
developed and written by David Barrett from FHSC.
- The independent evaluation of the Telehealth Hub project by 2020Health
(with activity and outcome summaries by the University of Hull) can be
found at;
http://www.2020health.org/2020health/Press/latest-news/Yorkshire-Telehealth.html
- A full list of reference sites and their star ratings can be found at
http://europa.eu/rapid/press-release_IP-13-633_en.htm
and a full description of sites is available at http://ec.europa.eu/digital-agenda/en/news/excellent-innovation-ageing-european-guide-reference-sites-european-innovation-partnership
- Details of the best practice exchange of which the University is part
can be found at
http://www.2020health.org/2020health/Press/latest-news/Making-Connections.html
- Findings from TEN-HMS data are cited in European Heart Failure
guidelines:
Lainscak M et al. Self-care management of heart failure: practical
recommendations from the Patient Care Committee of the Heart Failure
Association of the European Society of Cardiology Eur J Heart Fail
2011: 13(2): 115-126.
- The Health Technology Assessment of telemonitoring in recently
discharged heart failure patients (which includes findings from TEN-HMS)
can be found at
http://www.journalslibrary.nihr.ac.uk/__data/assets/pdf_file/0007/76588/FullReport-hta17320.pdf
- A letter of support from Philips Healthcare.
- Skills for Care Assistive Technology Workforce development resources
developed in partnership with the University of Hull can be found at;
http://www.skillsforcare.org.uk/developing_skills/assistedlivingtechnologyresourcehub/assisted_living_technology_resource_hub.aspx